Clinical Trial Update: ACTHar in the Treatment of Lupus Nephritis [Phase 4]

View source ↗

Summary

A Phase 4 trial of Acthar Gel for lupus nephritis has been terminated, and results have been posted. The study sponsor is Columbia University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Columbia University | Conditions: Lupus Nephritis | Phase 4 | Status: TERMINATED | Results posted: 2025-03-07